| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.008 | 0.878 | Antiinflammatory | 0.878 0.007 DBMET02876 0.878 0.007 DBMET02877 | DBMET02877 | |
| 0.726 | 0.004 | 0.726 | Non-steroidal antiinflammatory agent | 0.505 0.006 DBMET02876 0.505 0.006 DBMET02877 | ||
| 0.669 | 0.017 | 0.717 | Analgesic | 0.717 0.012 DBMET02876 0.717 0.012 DBMET02877 | DBMET02877 | |
| 0.622 | 0.004 | 0.622 | Cyclooxygenase 1 inhibitor | 0.556 0.004 DBMET02876 0.556 0.004 DBMET02877 | ||
| 0.601 | 0.019 | 0.658 | Cholesterol antagonist | 0.658 0.012 DBMET02876 0.658 0.012 DBMET02877 | DBMET02877 | |
| 0.58 | 0.016 | 0.58 | Immunosuppressant | 0.545 0.022 DBMET02876 0.545 0.022 DBMET02877 | ||
| 0.567 | 0.005 | 0.623 | Anesthetic general | 0.623 0.004 DBMET02876 0.623 0.004 DBMET02877 | DBMET02877 | |
| 0.452 | 0.005 | 0.452 | Cyclooxygenase inhibitor | 0.381 0.009 DBMET02876 0.381 0.009 DBMET02877 | ||
| 0.474 | 0.033 | 0.563 | Antithrombotic | 0.563 0.02 DBMET02876 0.563 0.02 DBMET02877 | DBMET02877 | |
| 0.474 | 0.034 | 0.556 | Vasodilator, peripheral | 0.556 0.02 DBMET02876 0.556 0.02 DBMET02877 | DBMET02877 | |
| 0.483 | 0.047 | 0.511 | Transcription factor NF kappa B inhibitor | 0.511 0.043 DBMET02876 0.511 0.043 DBMET02877 | DBMET02877 | |
| 0.443 | 0.008 | 0.456 | Sodium/bile acid cotransporter inhibitor | 0.456 0.007 DBMET02876 0.456 0.007 DBMET02877 | DBMET02877 | |
| 0.442 | 0.013 | 0.484 | Calcium channel activator | 0.484 0.006 DBMET02876 0.484 0.006 DBMET02877 | DBMET02877 | |
| 0.42 | 0.005 | 0.42 | Amyloid beta precursor protein antagonist | 0.391 0.007 DBMET02876 0.391 0.007 DBMET02877 | ||
| 0.434 | 0.02 | 0.434 | Amyloid beta aggregation inhibitor | 0.251 0.058 DBMET02876 0.251 0.058 DBMET02877 | ||
| 0.394 | 0.005 | 0.394 | Gastrin inhibitor | 0.375 0.006 DBMET02876 0.375 0.006 DBMET02877 | ||
| 0.393 | 0.029 | 0.399 | Interleukin 2 agonist | 0.399 0.028 DBMET02876 0.399 0.028 DBMET02877 | DBMET02877 | |
| 0.378 | 0.029 | 0.415 | Hypolipemic | 0.415 0.023 DBMET02876 0.415 0.023 DBMET02877 | DBMET02877 | |
| 0.418 | 0.081 | 0.543 | Cyclophilin D inhibitor | 0.543 0.039 DBMET02876 0.543 0.039 DBMET02877 | DBMET02877 | |
| 0.406 | 0.077 | 0.406 | Calcium channel L-type activator | 0.335 0.129 DBMET02876 0.335 0.129 DBMET02877 | ||
| 0.338 | 0.015 | 0.458 | Phospholipase C inhibitor | 0.458 0.007 DBMET02876 0.458 0.007 DBMET02877 | DBMET02877 | |
| 0.329 | 0.01 | 0.329 | Cyclooxygenase 2 inhibitor | 0.273 0.017 DBMET02876 0.273 0.017 DBMET02877 | ||
| 0.418 | 0.1 | 0.59 | Caspase 9 stimulant | 0.59 0.038 DBMET02876 0.59 0.038 DBMET02877 | DBMET02877 | |
| 0.353 | 0.038 | 0.353 | Interleukin antagonist | 0.227 0.071 DBMET02876 0.227 0.071 DBMET02877 | ||
| 0.321 | 0.012 | 0.376 | Interleukin 6 antagonist | 0.376 0.009 DBMET02876 0.376 0.009 DBMET02877 | DBMET02877 | |
| 0.313 | 0.01 | 0.313 | Chelator | 0.25 0.016 DBMET02876 0.25 0.016 DBMET02877 | ||
| 0.343 | 0.04 | 0.439 | Platelet antagonist | 0.439 0.021 DBMET02876 0.439 0.021 DBMET02877 | DBMET02877 | |
| 0.33 | 0.043 | 0.419 | Hypoglycemic | 0.419 0.025 DBMET02876 0.419 0.025 DBMET02877 | DBMET02877 | |
| 0.292 | 0.007 | 0.379 | ATPase inhibitor | 0.379 0.004 DBMET02876 0.379 0.004 DBMET02877 | DBMET02877 | |
| 0.338 | 0.056 | 0.44 | Spasmolytic | 0.44 0.033 DBMET02876 0.44 0.033 DBMET02877 | DBMET02877 | |
| 0.299 | 0.021 | 0.299 | Lipocortins synthesis antagonist | 0.282 0.025 DBMET02876 0.282 0.025 DBMET02877 | ||
| 0.278 | 0.016 | 0.278 | Acetylcholinesterase inhibitor | |||
| 0.308 | 0.048 | 0.318 | Superoxide dismutase inhibitor | 0.318 0.044 DBMET02876 0.318 0.044 DBMET02877 | DBMET02877 | |
| 0.263 | 0.004 | 0.266 | Arachidonic acid antagonist | 0.266 0.004 DBMET02876 0.266 0.004 DBMET02877 | DBMET02877 | |
| 0.279 | 0.023 | 0.303 | Interferon gamma antagonist | 0.303 0.019 DBMET02876 0.303 0.019 DBMET02877 | DBMET02877 | |
| 0.261 | 0.008 | 0.282 | Cyclooxygenase 3 inhibitor | 0.282 0.007 DBMET02876 0.282 0.007 DBMET02877 | DBMET02877 | |
| 0.312 | 0.069 | 0.312 | Nootropic | |||
| 0.302 | 0.061 | 0.304 | Antioxidant | 0.304 0.06 DBMET02876 0.304 0.06 DBMET02877 | DBMET02877 | |
| 0.291 | 0.055 | 0.291 | Antiamyloidogenic | 0.191 0.106 DBMET02876 0.191 0.106 DBMET02877 | ||
| 0.247 | 0.014 | 0.247 | GABA C receptor agonist | 0.203 0.02 DBMET02876 0.203 0.02 DBMET02877 | ||
| 0.297 | 0.073 | 0.297 | Lipoxygenase inhibitor | 0.203 0.137 DBMET02876 0.203 0.137 DBMET02877 | ||
| 0.272 | 0.05 | 0.272 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 DBMET02876 0.223 0.099 DBMET02877 | ||
| 0.249 | 0.029 | 0.249 | Cholinergic | |||
| 0.242 | 0.025 | 0.242 | Phospholipase A2 inhibitor | 0.224 0.032 DBMET02876 0.224 0.032 DBMET02877 | ||
| 0.249 | 0.034 | 0.259 | Thrombolytic | 0.259 0.031 DBMET02876 0.259 0.031 DBMET02877 | DBMET02877 | |
| 0.273 | 0.061 | 0.273 | 5 Hydroxytryptamine uptake stimulant | 0.266 0.067 DBMET02876 0.266 0.067 DBMET02877 | ||
| 0.257 | 0.05 | 0.283 | Nitric oxide antagonist | 0.283 0.044 DBMET02876 0.283 0.044 DBMET02877 | DBMET02877 | |
| 0.211 | 0.005 | 0.211 | Interleukin 5 antagonist | 0.121 0.023 DBMET02876 0.121 0.023 DBMET02877 | ||
| 0.229 | 0.032 | 0.268 | Protein kinase stimulant | 0.268 0.022 DBMET02876 0.268 0.022 DBMET02877 | DBMET02877 | |
| 0.221 | 0.029 | 0.395 | Alpha-N-acetylglucosaminidase inhibitor | 0.395 0.009 DBMET02876 0.395 0.009 DBMET02877 | DBMET02877 | |
| 0.26 | 0.071 | 0.284 | Interleukin agonist | 0.284 0.056 DBMET02876 0.284 0.056 DBMET02877 | DBMET02877 | |
| 0.198 | 0.009 | 0.198 | ABCA1 expression enhancer | 0.183 0.011 DBMET02876 0.183 0.011 DBMET02877 | ||
| 0.28 | 0.094 | 0.492 | Immunomodulator | 0.492 0.024 DBMET02876 0.492 0.024 DBMET02877 | DBMET02877 | |
| 0.266 | 0.083 | 0.266 | Insulysin inhibitor | 0.219 0.13 DBMET02876 0.219 0.13 DBMET02877 | ||
| 0.195 | 0.013 | 0.215 | Vanilloid 1 agonist | 0.215 0.009 DBMET02876 0.215 0.009 DBMET02877 | DBMET02877 | |
| 0.303 | 0.122 | 0.311 | Histamine release inhibitor | 0.311 0.118 DBMET02876 0.311 0.118 DBMET02877 | DBMET02877 | |
| 0.246 | 0.07 | 0.246 | Free radical scavenger | 0.209 0.091 DBMET02876 0.209 0.091 DBMET02877 | ||
| 0.185 | 0.013 | 0.21 | Triose-phosphate isomerase inhibitor | 0.21 0.01 DBMET02876 0.21 0.01 DBMET02877 | DBMET02877 | |
| 0.226 | 0.054 | 0.234 | Neurotrophic factor enhancer | 0.234 0.048 DBMET02876 0.234 0.048 DBMET02877 | DBMET02877 | |
| 0.176 | 0.017 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | 0.192 0.013 DBMET02876 0.192 0.013 DBMET02877 | DBMET02877 | |
| 0.178 | 0.02 | 0.178 | Interleukin 8 antagonist | 0.142 0.04 DBMET02876 0.142 0.04 DBMET02877 | ||
| 0.177 | 0.026 | 0.223 | Microtubule formation inhibitor | 0.223 0.015 DBMET02876 0.223 0.015 DBMET02877 | DBMET02877 | |
| 0.21 | 0.059 | 0.275 | Hepatoprotectant | 0.275 0.037 DBMET02876 0.275 0.037 DBMET02877 | DBMET02877 | |
| 0.191 | 0.041 | 0.24 | Insulin secretagoues | 0.24 0.021 DBMET02876 0.24 0.021 DBMET02877 | DBMET02877 | |
| 0.195 | 0.053 | 0.195 | Succinate dehydrogenase inhibitor | 0.162 0.092 DBMET02876 0.162 0.092 DBMET02877 | ||
| 0.194 | 0.053 | 0.196 | Antipruritic | 0.196 0.052 DBMET02876 0.196 0.052 DBMET02877 | DBMET02877 | |
| 0.145 | 0.006 | 0.145 | Peroxisome proliferator-activated receptor gamma antagonist | 0.088 0.024 DBMET02876 0.088 0.024 DBMET02877 | ||
| 0.151 | 0.013 | 0.151 | Aromatase inhibitor | 0.078 0.029 DBMET02876 0.078 0.029 DBMET02877 | ||
| 0.215 | 0.08 | 0.221 | RNA-directed DNA polymerase inhibitor | 0.221 0.073 DBMET02876 0.221 0.073 DBMET02877 | DBMET02877 | |
| 0.154 | 0.02 | 0.154 | Carbonic anhydrase VI inhibitor | 0.138 0.024 DBMET02876 0.138 0.024 DBMET02877 | ||
| 0.17 | 0.036 | 0.272 | Cholesterol synthesis inhibitor | 0.272 0.015 DBMET02876 0.272 0.015 DBMET02877 | DBMET02877 | |
| 0.143 | 0.01 | 0.143 | T cell inhibitor | 0.115 0.016 DBMET02876 0.115 0.016 DBMET02877 | ||
| 0.136 | 0.005 | 0.136 | Thromboxane antagonist | 0.128 0.006 DBMET02876 0.128 0.006 DBMET02877 | ||
| 0.167 | 0.037 | 0.175 | Cell adhesion inhibitor | 0.175 0.033 DBMET02876 0.175 0.033 DBMET02877 | DBMET02877 | |
| 0.158 | 0.028 | 0.203 | Mucolytic | 0.203 0.013 DBMET02876 0.203 0.013 DBMET02877 | DBMET02877 | |
| 0.207 | 0.077 | 0.249 | Platelet aggregation inhibitor | 0.249 0.052 DBMET02876 0.249 0.052 DBMET02877 | DBMET02877 | |
| 0.137 | 0.007 | 0.137 | 5-Alpha-reductase inhibitor | 0.076 0.013 DBMET02876 0.076 0.013 DBMET02877 | ||
| 0.139 | 0.01 | 0.189 | Bile acid receptor antagonist | 0.189 0.005 DBMET02876 0.189 0.005 DBMET02877 | DBMET02877 | |
| 0.139 | 0.011 | 0.168 | Prostaglandin EP2 antagonist | 0.168 0.008 DBMET02876 0.168 0.008 DBMET02877 | DBMET02877 | |
| 0.13 | 0.004 | 0.13 | Peroxisome proliferator-activated receptor alpha antagonist | 0.03 0.011 DBMET02876 0.03 0.011 DBMET02877 | ||
| 0.145 | 0.021 | 0.145 | Anabolic | 0.143 0.022 DBMET02876 0.143 0.022 DBMET02877 | ||
| 0.146 | 0.024 | 0.163 | Prolactin inhibitor | 0.163 0.017 DBMET02876 0.163 0.017 DBMET02877 | DBMET02877 | |
| 0.155 | 0.034 | 0.238 | Expectorant | 0.238 0.014 DBMET02876 0.238 0.014 DBMET02877 | DBMET02877 | |
| 0.191 | 0.07 | 0.191 | P-glycoprotein inhibitor | |||
| 0.147 | 0.033 | 0.147 | TRPA1 agonist | 0.131 0.046 DBMET02876 0.131 0.046 DBMET02877 | ||
| 0.287 | 0.181 | 0.448 | Apoptosis agonist | 0.448 0.092 DBMET02876 0.448 0.092 DBMET02877 | DBMET02877 | |
| 0.123 | 0.019 | 0.123 | Peroxisome proliferator-activated receptor gamma agonist | 0.099 0.028 DBMET02876 0.099 0.028 DBMET02877 | ||
| 0.285 | 0.182 | 0.285 | 5 Hydroxytryptamine release inhibitor | |||
| 0.108 | 0.005 | 0.108 | CXC chemokine 1 receptor antagonist | 0.086 0.007 DBMET02876 0.086 0.007 DBMET02877 | ||
| 0.125 | 0.022 | 0.128 | Ornithine decarboxylase inhibitor | 0.128 0.02 DBMET02876 0.128 0.02 DBMET02877 | DBMET02877 | |
| 0.152 | 0.05 | 0.156 | Pregnane X receptor agonist | 0.156 0.043 DBMET02876 0.156 0.043 DBMET02877 | DBMET02877 | |
| 0.187 | 0.088 | 0.2 | Insulin sensitizer | 0.2 0.073 DBMET02876 0.2 0.073 DBMET02877 | DBMET02877 | |
| 0.237 | 0.14 | 0.3 | Apoptosis antagonist | 0.3 0.085 DBMET02876 0.3 0.085 DBMET02877 | DBMET02877 | |
| 0.116 | 0.02 | 0.124 | Vanilloid agonist | 0.124 0.017 DBMET02876 0.124 0.017 DBMET02877 | DBMET02877 | |
| 0.13 | 0.035 | 0.142 | Toll-Like receptor 4 antagonist | 0.142 0.025 DBMET02876 0.142 0.025 DBMET02877 | DBMET02877 | |
| 0.144 | 0.049 | 0.144 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.07 DBMET02876 0.132 0.07 DBMET02877 | ||
| 0.261 | 0.167 | 0.378 | Antibacterial | 0.378 0.087 DBMET02876 0.378 0.087 DBMET02877 | DBMET02877 | |
| 0.098 | 0.005 | 0.098 | AMPA 4 receptor antagonist | 0.077 0.007 DBMET02876 0.077 0.007 DBMET02877 | ||
| 0.111 | 0.018 | 0.169 | Leukotriene antagonist | 0.169 0.008 DBMET02876 0.169 0.008 DBMET02877 | DBMET02877 | |
| 0.103 | 0.01 | 0.103 | NMDA receptor subunit 3B antagonist | 0.077 0.014 DBMET02876 0.077 0.014 DBMET02877 | ||
| 0.103 | 0.012 | 0.103 | Peroxisome proliferator-activated receptor alpha agonist | 0.095 0.013 DBMET02876 0.095 0.013 DBMET02877 | ||
| 0.098 | 0.008 | 0.103 | Thromboxane A2 antagonist | 0.103 0.007 DBMET02876 0.103 0.007 DBMET02877 | DBMET02877 | |
| 0.095 | 0.005 | 0.095 | Retinoid X alpha receptor agonist | 0.056 0.012 DBMET02876 0.056 0.012 DBMET02877 | ||
| 0.107 | 0.018 | 0.107 | Argininosuccinate synthase inhibitor | 0.093 0.021 DBMET02876 0.093 0.021 DBMET02877 | ||
| 0.106 | 0.016 | 0.106 | Prostaglandin antagonist | 0.097 0.018 DBMET02876 0.097 0.018 DBMET02877 | ||
| 0.145 | 0.057 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 DBMET02876 0.157 0.028 DBMET02877 | DBMET02877 | |
| 0.13 | 0.043 | 0.13 | GABA C receptor antagonist | 0.111 0.062 DBMET02876 0.111 0.062 DBMET02877 | ||
| 0.092 | 0.007 | 0.092 | DNA helicase inhibitor | 0.084 0.009 DBMET02876 0.084 0.009 DBMET02877 | ||
| 0.09 | 0.006 | 0.09 | Retinoid X receptor agonist | 0.065 0.012 DBMET02876 0.065 0.012 DBMET02877 | ||
| 0.108 | 0.025 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DBMET02876 0.116 0.019 DBMET02877 | DBMET02877 | |
| 0.148 | 0.065 | 0.201 | Adenylate cyclase stimulant | 0.201 0.013 DBMET02876 0.201 0.013 DBMET02877 | DBMET02877 | |
| 0.1 | 0.018 | 0.128 | Alcohol oxidase inhibitor | 0.128 0.013 DBMET02876 0.128 0.013 DBMET02877 | DBMET02877 | |
| 0.085 | 0.003 | 0.085 | CYP24 inhibitor | 0.027 0.012 DBMET02876 0.027 0.012 DBMET02877 | ||
| 0.215 | 0.135 | 0.215 | Hypoxia-inducible factor 1 alpha inhibitor | 0.196 0.156 DBMET02876 0.196 0.156 DBMET02877 | ||
| 0.147 | 0.067 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.154 | 0.076 | 0.185 | Melanin inhibitor | 0.185 0.048 DBMET02876 0.185 0.048 DBMET02877 | DBMET02877 | |
| 0.083 | 0.006 | 0.083 | Prostaglandin agonist | 0.075 0.007 DBMET02876 0.075 0.007 DBMET02877 | ||
| 0.134 | 0.058 | 0.174 | DNA polymerase I inhibitor | 0.174 0.037 DBMET02876 0.174 0.037 DBMET02877 | DBMET02877 | |
| 0.086 | 0.012 | 0.086 | Aconitate hydratase inhibitor | 0.072 0.017 DBMET02876 0.072 0.017 DBMET02877 | ||
| 0.1 | 0.026 | 0.1 | Leukotriene synthesis inhibitor | 0.07 0.044 DBMET02876 0.07 0.044 DBMET02877 | ||
| 0.139 | 0.066 | 0.155 | Farnesoid X receptor antagonist | 0.155 0.047 DBMET02876 0.155 0.047 DBMET02877 | DBMET02877 | |
| 0.131 | 0.059 | 0.15 | Anesthetic local | 0.15 0.049 DBMET02876 0.15 0.049 DBMET02877 | DBMET02877 | |
| 0.126 | 0.054 | 0.126 | Cystathionine beta-synthase inhibitor | 0.108 0.068 DBMET02876 0.108 0.068 DBMET02877 | ||
| 0.083 | 0.013 | 0.083 | Diacylglycerol O-acyltransferase inhibitor | 0.078 0.015 DBMET02876 0.078 0.015 DBMET02877 | ||
| 0.093 | 0.023 | 0.094 | GABA B receptor agonist | 0.094 0.022 DBMET02876 0.094 0.022 DBMET02877 | DBMET02877 | |
| 0.073 | 0.004 | 0.073 | Prostaglandin EP4 agonist | 0.044 0.005 DBMET02876 0.044 0.005 DBMET02877 | ||
| 0.117 | 0.049 | 0.117 | DOPA decarboxylase inhibitor | |||
| 0.125 | 0.058 | 0.125 | Monophenol monooxygenase inhibitor | 0.108 0.07 DBMET02876 0.108 0.07 DBMET02877 | ||
| 0.1 | 0.034 | 0.125 | Cell adhesion molecule inhibitor | 0.125 0.022 DBMET02876 0.125 0.022 DBMET02877 | DBMET02877 | |
| 0.115 | 0.05 | 0.115 | Butyrylcholinesterase inhibitor | |||
| 0.127 | 0.062 | 0.181 | Adenylate cyclase inhibitor | 0.181 0.03 DBMET02876 0.181 0.03 DBMET02877 | DBMET02877 | |
| 0.083 | 0.019 | 0.083 | NMDA 2A receptor antagonist | 0.046 0.042 DBMET02876 0.046 0.042 DBMET02877 | ||
| 0.075 | 0.012 | 0.082 | Ryanodine receptor antagonist | 0.082 0.008 DBMET02876 0.082 0.008 DBMET02877 | DBMET02877 | |
| 0.095 | 0.033 | 0.095 | Keratolytic | 0.077 0.052 DBMET02876 0.077 0.052 DBMET02877 | ||
| 0.145 | 0.084 | 0.145 | Hexokinase inhibitor | 0.127 0.108 DBMET02876 0.127 0.108 DBMET02877 | ||
| 0.089 | 0.028 | 0.156 | Glycine receptor agonist | 0.156 0.006 DBMET02876 0.156 0.006 DBMET02877 | DBMET02877 | |
| 0.082 | 0.024 | 0.082 | NMDA 2C receptor antagonist | 0.068 0.035 DBMET02876 0.068 0.035 DBMET02877 | ||
| 0.118 | 0.059 | 0.118 | Estrogen antagonist | 0.104 0.088 DBMET02876 0.104 0.088 DBMET02877 | ||
| 0.072 | 0.014 | 0.072 | NMDA receptor subunit 3A antagonist | 0.059 0.017 DBMET02876 0.059 0.017 DBMET02877 | ||
| 0.073 | 0.015 | 0.075 | Thromboxane synthase inhibitor | 0.075 0.014 DBMET02876 0.075 0.014 DBMET02877 | DBMET02877 | |
| 0.102 | 0.045 | 0.102 | Androgen antagonist | 0.083 0.062 DBMET02876 0.083 0.062 DBMET02877 | ||
| 0.07 | 0.014 | 0.07 | Pregnane X receptor antagonist | |||
| 0.08 | 0.023 | 0.08 | Aldose reductase inhibitor | 0.052 0.037 DBMET02876 0.052 0.037 DBMET02877 | ||
| 0.061 | 0.004 | 0.061 | Prostaglandin EP2 agonist | 0.052 0.005 DBMET02876 0.052 0.005 DBMET02877 | ||
| 0.108 | 0.052 | 0.113 | UDP-glucose 4-epimerase inhibitor | 0.113 0.049 DBMET02876 0.113 0.049 DBMET02877 | DBMET02877 | |
| 0.08 | 0.024 | 0.086 | Glutamate (mGluR6) antagonist | 0.086 0.019 DBMET02876 0.086 0.019 DBMET02877 | DBMET02877 | |
| 0.107 | 0.052 | 0.107 | Creatine kinase inhibitor | 0.084 0.08 DBMET02876 0.084 0.08 DBMET02877 | ||
| 0.094 | 0.039 | 0.094 | Porphobilinogen synthase inhibitor | |||
| 0.067 | 0.012 | 0.111 | Cholesterol esterase inhibitor | 0.111 0.004 DBMET02876 0.111 0.004 DBMET02877 | DBMET02877 | |
| 0.097 | 0.044 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.014 DBMET02876 0.129 0.014 DBMET02877 | DBMET02877 | |
| 0.089 | 0.036 | 0.089 | GABA aminotransferase inhibitor | 0.077 0.05 DBMET02876 0.077 0.05 DBMET02877 | ||
| 0.077 | 0.025 | 0.085 | Nitric oxide donor | 0.085 0.018 DBMET02876 0.085 0.018 DBMET02877 | DBMET02877 | |
| 0.063 | 0.011 | 0.068 | Liver X receptor alpha agonist | 0.068 0.009 DBMET02876 0.068 0.009 DBMET02877 | DBMET02877 | |
| 0.171 | 0.122 | 0.206 | Aldehyde oxidase inhibitor | 0.206 0.102 DBMET02876 0.206 0.102 DBMET02877 | DBMET02877 | |
| 0.087 | 0.039 | 0.087 | Estrogen receptor alpha antagonist | 0.074 0.059 DBMET02876 0.074 0.059 DBMET02877 | ||
| 0.068 | 0.02 | 0.068 | CC chemokine 5 receptor antagonist | 0.058 0.028 DBMET02876 0.058 0.028 DBMET02877 | ||
| 0.216 | 0.168 | 0.309 | Vasodilator, coronary | 0.309 0.08 DBMET02876 0.309 0.08 DBMET02877 | DBMET02877 | |
| 0.067 | 0.02 | 0.067 | Dihydroorotate oxidase inhibitor | |||
| 0.054 | 0.007 | 0.054 | Melatonin receptor 1A agonist | 0.036 0.019 DBMET02876 0.036 0.019 DBMET02877 | ||
| 0.056 | 0.009 | 0.056 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.149 | 0.103 | 0.149 | Neurotensin receptor agonist | |||
| 0.052 | 0.008 | 0.052 | AMPA receptor agonist | 0.034 0.026 DBMET02876 0.034 0.026 DBMET02877 | ||
| 0.054 | 0.01 | 0.054 | Retinoid X receptor antagonist | 0.041 0.022 DBMET02876 0.041 0.022 DBMET02877 | ||
| 0.062 | 0.018 | 0.062 | Carbonic anhydrase IV inhibitor | 0.055 0.022 DBMET02876 0.055 0.022 DBMET02877 | ||
| 0.123 | 0.079 | 0.225 | Amylase inhibitor | 0.225 0.036 DBMET02876 0.225 0.036 DBMET02877 | DBMET02877 | |
| 0.05 | 0.008 | 0.05 | Lysine carboxypeptidase inhibitor | 0.043 0.009 DBMET02876 0.043 0.009 DBMET02877 | ||
| 0.102 | 0.06 | 0.102 | Estrogen receptor beta antagonist | |||
| 0.163 | 0.122 | 0.163 | Histone acetyltransferase inhibitor | |||
| 0.052 | 0.011 | 0.074 | Glutamate (mGluR3) antagonist | 0.074 0.005 DBMET02876 0.074 0.005 DBMET02877 | DBMET02877 | |
| 0.082 | 0.041 | 0.082 | CDC25A inhibitor | 0.073 0.053 DBMET02876 0.073 0.053 DBMET02877 | ||
| 0.087 | 0.046 | 0.101 | Estrogen-related receptor beta agonist | 0.101 0.023 DBMET02876 0.101 0.023 DBMET02877 | DBMET02877 | |
| 0.07 | 0.03 | 0.09 | Androgen agonist | 0.09 0.019 DBMET02876 0.09 0.019 DBMET02877 | DBMET02877 | |
| 0.098 | 0.058 | 0.127 | Lanosterol 14 alpha demethylase inhibitor | 0.127 0.024 DBMET02876 0.127 0.024 DBMET02877 | DBMET02877 | |
| 0.048 | 0.008 | 0.072 | Prostaglandin D2 agonist | 0.072 0.004 DBMET02876 0.072 0.004 DBMET02877 | DBMET02877 | |
| 0.048 | 0.009 | 0.048 | Prostaglandin EP4 antagonist | 0.041 0.01 DBMET02876 0.041 0.01 DBMET02877 | ||
| 0.047 | 0.008 | 0.047 | Retinoid X alpha receptor antagonist | 0.036 0.02 DBMET02876 0.036 0.02 DBMET02877 | ||
| 0.053 | 0.014 | 0.053 | Membrane dipeptidase inhibitor | 0.042 0.024 DBMET02876 0.042 0.024 DBMET02877 | ||
| 0.101 | 0.064 | 0.101 | Aminopeptidase B inhibitor | 0.096 0.068 DBMET02876 0.096 0.068 DBMET02877 | ||
| 0.132 | 0.095 | 0.154 | NOS3 expression enhancer | 0.154 0.069 DBMET02876 0.154 0.069 DBMET02877 | DBMET02877 | |
| 0.152 | 0.115 | 0.152 | Psychostimulant | |||
| 0.084 | 0.047 | 0.095 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.095 0.04 DBMET02876 0.095 0.04 DBMET02877 | DBMET02877 | |
| 0.042 | 0.005 | 0.042 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET02876 0.026 0.019 DBMET02877 | ||
| 0.043 | 0.007 | 0.043 | Prostaglandin E2 agonist | 0.036 0.008 DBMET02876 0.036 0.008 DBMET02877 | ||
| 0.05 | 0.015 | 0.05 | Nicotinic acid receptor agonist | 0.033 0.029 DBMET02876 0.033 0.029 DBMET02877 | ||
| 0.049 | 0.015 | 0.055 | Kainate receptor agonist | 0.055 0.009 DBMET02876 0.055 0.009 DBMET02877 | DBMET02877 | |
| 0.164 | 0.13 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 DBMET02876 0.167 0.126 DBMET02877 | DBMET02877 | |
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | 0.043 0.014 DBMET02876 0.043 0.014 DBMET02877 | ||
| 0.094 | 0.061 | 0.119 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.119 0.039 DBMET02876 0.119 0.039 DBMET02877 | DBMET02877 | |
| 0.038 | 0.006 | 0.054 | Prostaglandin F2 alpha agonist | 0.054 0.004 DBMET02876 0.054 0.004 DBMET02877 | DBMET02877 | |
| 0.07 | 0.038 | 0.077 | MDM2 inhibitor | 0.077 0.024 DBMET02876 0.077 0.024 DBMET02877 | DBMET02877 | |
| 0.087 | 0.057 | 0.148 | NMDA receptor antagonist | 0.148 0.025 DBMET02876 0.148 0.025 DBMET02877 | DBMET02877 | |
| 0.077 | 0.047 | 0.077 | Cathepsin G inhibitor | |||
| 0.037 | 0.007 | 0.037 | Thyroid hormone agonist | 0.031 0.011 DBMET02876 0.031 0.011 DBMET02877 | ||
| 0.084 | 0.055 | 0.084 | Inducible nitric-oxide synthase inhibitor | |||
| 0.077 | 0.047 | 0.077 | Glutamate decarboxylase inhibitor | |||
| 0.095 | 0.068 | 0.095 | 5-Lipoxygenase inhibitor | |||
| 0.058 | 0.031 | 0.058 | Estrogen agonist | |||
| 0.158 | 0.131 | 0.188 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.188 0.084 DBMET02876 0.188 0.084 DBMET02877 | DBMET02877 | |
| 0.061 | 0.034 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 DBMET02876 0.067 0.025 DBMET02877 | DBMET02877 | |
| 0.035 | 0.009 | 0.037 | Prostaglandin H2 antagonist | 0.037 0.008 DBMET02876 0.037 0.008 DBMET02877 | DBMET02877 | |
| 0.08 | 0.053 | 0.08 | Glutamate receptor agonist | |||
| 0.167 | 0.141 | 0.253 | Immunostimulant | 0.253 0.095 DBMET02876 0.253 0.095 DBMET02877 | DBMET02877 | |
| 0.098 | 0.073 | 0.098 | Ferrochelatase inhibitor | |||
| 0.065 | 0.04 | 0.065 | Kallikrein 7 inhibitor | 0.061 0.052 DBMET02876 0.061 0.052 DBMET02877 | ||
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | 0.023 0.01 DBMET02876 0.023 0.01 DBMET02877 | ||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | 0.039 0.028 DBMET02876 0.039 0.028 DBMET02877 | ||
| 0.041 | 0.017 | 0.044 | Prostacyclin antagonist | 0.044 0.016 DBMET02876 0.044 0.016 DBMET02877 | DBMET02877 | |
| 0.038 | 0.015 | 0.038 | Carboxypeptidase B inhibitor | 0.038 0.015 DBMET02876 0.038 0.015 DBMET02877 | ||
| 0.027 | 0.005 | 0.027 | CXC chemokine 5 receptor antagonist | 0.025 0.005 DBMET02876 0.025 0.005 DBMET02877 | ||
| 0.092 | 0.07 | 0.092 | Electrolyte absorption antagonist | 0.086 0.083 DBMET02876 0.086 0.083 DBMET02877 | ||
| 0.036 | 0.015 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 DBMET02876 0.037 0.013 DBMET02877 | DBMET02877 | |
| 0.037 | 0.016 | 0.039 | ATP citrate lysase inhibitor | 0.039 0.013 DBMET02876 0.039 0.013 DBMET02877 | DBMET02877 | |
| 0.099 | 0.079 | 0.148 | Protein-tyrosine phosphatase 1B inhibitor | 0.148 0.046 DBMET02876 0.148 0.046 DBMET02877 | DBMET02877 | |
| 0.037 | 0.018 | 0.048 | HMG CoA reductase inhibitor | 0.048 0.008 DBMET02876 0.048 0.008 DBMET02877 | DBMET02877 | |
| 0.102 | 0.084 | 0.102 | Proteasome inhibitor | |||
| 0.054 | 0.036 | 0.059 | Leukotriene B4 antagonist | 0.059 0.029 DBMET02876 0.059 0.029 DBMET02877 | DBMET02877 | |
| 0.109 | 0.091 | 0.109 | Toll-Like receptor 2 antagonist | |||
| 0.067 | 0.05 | 0.105 | Phosphofructokinase-1 inhibitor | 0.105 0.03 DBMET02876 0.105 0.03 DBMET02877 | DBMET02877 | |
| 0.03 | 0.013 | 0.03 | Retinoid X gamma receptor antagonist | 0.027 0.019 DBMET02876 0.027 0.019 DBMET02877 | ||
| 0.143 | 0.127 | 0.228 | Angiogenesis stimulant | 0.228 0.08 DBMET02876 0.228 0.08 DBMET02877 | DBMET02877 | |
| 0.02 | 0.004 | 0.02 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.024 | 0.008 | 0.024 | Progesterone receptor B antagonist | 0.02 0.012 DBMET02876 0.02 0.012 DBMET02877 | ||
| 0.021 | 0.006 | 0.021 | Thyroid hormone alpha agonist | 0.02 0.007 DBMET02876 0.02 0.007 DBMET02877 | ||
| 0.035 | 0.02 | 0.035 | Liver X receptor beta agonist | |||
| 0.045 | 0.031 | 0.055 | Parathyroid hormone antagonist | 0.055 0.015 DBMET02876 0.055 0.015 DBMET02877 | DBMET02877 | |
| 0.069 | 0.055 | 0.075 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET02876 0.075 0.047 DBMET02877 | DBMET02877 | |
| 0.043 | 0.03 | 0.043 | Opioid kappa receptor agonist | |||
| 0.089 | 0.076 | 0.16 | Bronchodilator | 0.16 0.028 DBMET02876 0.16 0.028 DBMET02877 | DBMET02877 | |
| 0.023 | 0.011 | 0.023 | 5-Alpha-reductase 2 inhibitor | |||
| 0.08 | 0.069 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.046 | 0.036 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DBMET02876 0.062 0.017 DBMET02877 | DBMET02877 | |
| 0.03 | 0.019 | 0.03 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.026 0.023 DBMET02876 0.026 0.023 DBMET02877 | ||
| 0.173 | 0.163 | 0.221 | DNA synthesis inhibitor | 0.221 0.093 DBMET02876 0.221 0.093 DBMET02877 | DBMET02877 | |
| 0.048 | 0.038 | 0.049 | Prostaglandin E2 antagonist | 0.049 0.036 DBMET02876 0.049 0.036 DBMET02877 | DBMET02877 | |
| 0.029 | 0.019 | 0.029 | Liver X receptor beta antagonist | |||
| 0.017 | 0.008 | 0.03 | Thromboxane A2 agonist | 0.03 0.003 DBMET02876 0.03 0.003 DBMET02877 | DBMET02877 | |
| 0.092 | 0.083 | 0.118 | Adenylate kinase inhibitor | 0.118 0.045 DBMET02876 0.118 0.045 DBMET02877 | DBMET02877 | |
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR8) agonist | 0.035 0.033 DBMET02876 0.035 0.033 DBMET02877 | ||
| 0.068 | 0.06 | 0.085 | Glutamate dehydrogenase inhibitor | 0.085 0.04 DBMET02876 0.085 0.04 DBMET02877 | DBMET02877 | |
| 0.102 | 0.094 | 0.102 | Aldehyde dehydrogenase inhibitor | |||
| 0.032 | 0.025 | 0.032 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.034 | 0.027 | 0.034 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.049 | 0.042 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 DBMET02876 0.07 0.024 DBMET02877 | DBMET02877 | |
| 0.013 | 0.006 | 0.031 | Thromboxane agonist | 0.031 0.003 DBMET02876 0.031 0.003 DBMET02877 | DBMET02877 | |
| 0.034 | 0.028 | 0.034 | Glutamate (mGluR8) antagonist | 0.034 0.028 DBMET02876 0.034 0.028 DBMET02877 | ||
| 0.041 | 0.035 | 0.041 | Alpha 1L adrenoreceptor agonist | |||
| 0.022 | 0.016 | 0.024 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 DBMET02876 0.024 0.013 DBMET02877 | DBMET02877 | |
| 0.054 | 0.048 | 0.085 | Biliverdin reductase inhibitor | 0.085 0.024 DBMET02876 0.085 0.024 DBMET02877 | DBMET02877 | |
| 0.041 | 0.036 | 0.06 | AICAR transformylase inhibitor | 0.06 0.014 DBMET02876 0.06 0.014 DBMET02877 | DBMET02877 | |
| 0.018 | 0.012 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET02876 0.019 0.011 DBMET02877 | DBMET02877 | |
| 0.027 | 0.023 | 0.035 | RNA-directed RNA polymerase stimulant | 0.035 0.019 DBMET02876 0.035 0.019 DBMET02877 | DBMET02877 | |
| 0.041 | 0.036 | 0.041 | Glutamate (mGluR4) antagonist | |||
| 0.012 | 0.007 | 0.013 | Calcineurin inhibitor | 0.013 0.006 DBMET02876 0.013 0.006 DBMET02877 | DBMET02877 | |
| 0.016 | 0.012 | 0.016 | 5-Alpha-reductase 1 inhibitor | |||
| 0.017 | 0.014 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.117 | 0.115 | 0.117 | Anticoagulant | |||
| 0.113 | 0.111 | 0.147 | Cell wall synthesis inhibitor | 0.147 0.068 DBMET02876 0.147 0.068 DBMET02877 | DBMET02877 | |
| 0.081 | 0.079 | 0.081 | Thioredoxin inhibitor | |||
| 0.036 | 0.034 | 0.041 | Vanilloid 3 antagonist | 0.041 0.019 DBMET02876 0.041 0.019 DBMET02877 | DBMET02877 | |
| 0.118 | 0.118 | 0.119 | Hemostatic | 0.119 0.117 DBMET02876 0.119 0.117 DBMET02877 | DBMET02877 | |
| 0.039 | 0.038 | 0.04 | Liver X receptor agonist | 0.04 0.036 DBMET02876 0.04 0.036 DBMET02877 | DBMET02877 | |
| 0.006 | 0.006 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET02876 0.006 0.005 DBMET02877 | DBMET02877 | |
| 0.013 | 0.014 | 0.062 | Prostacyclin agonist | 0.062 0.004 DBMET02876 0.062 0.004 DBMET02877 | DBMET02877 | |
| 0.023 | 0.024 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 DBMET02876 0.026 0.016 DBMET02877 | DBMET02877 | |
| 0.025 | 0.027 | 0.042 | Prostaglandin EP3 antagonist | 0.042 0.013 DBMET02876 0.042 0.013 DBMET02877 | DBMET02877 | |
| 0.102 | 0.104 | 0.127 | Bone formation stimulant | 0.127 0.079 DBMET02876 0.127 0.079 DBMET02877 | DBMET02877 | |
| 0.035 | 0.037 | 0.038 | Oxytocin agonist | 0.038 0.034 DBMET02876 0.038 0.034 DBMET02877 | DBMET02877 | |
| 0.014 | 0.017 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 DBMET02876 0.021 0.006 DBMET02877 | DBMET02877 | |
| 0.045 | 0.053 | 0.192 | NMDA 2B receptor antagonist | 0.192 0.006 DBMET02876 0.192 0.006 DBMET02877 | DBMET02877 | |
| 0.069 | 0.078 | 0.1 | Glycine receptor antagonist | 0.1 0.033 DBMET02876 0.1 0.033 DBMET02877 | DBMET02877 | |
| 0.013 | 0.023 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET02876 0.017 0.012 DBMET02877 | DBMET02877 | |
| 0.048 | 0.058 | 0.077 | Carbamoyl phosphate synthetase inhibitor | 0.077 0.03 DBMET02876 0.077 0.03 DBMET02877 | DBMET02877 | |
| 0.022 | 0.033 | 0.035 | LFA antagonist | 0.035 0.011 DBMET02876 0.035 0.011 DBMET02877 | DBMET02877 | |
| 0.018 | 0.029 | 0.027 | Vitamin D receptor antagonist | 0.027 0.009 DBMET02876 0.027 0.009 DBMET02877 | DBMET02877 | |
| 0.028 | 0.04 | 0.053 | Farnesoid X receptor agonist | 0.053 0.013 DBMET02876 0.053 0.013 DBMET02877 | DBMET02877 | |
| 0.017 | 0.029 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 DBMET02876 0.02 0.017 DBMET02877 | DBMET02877 | |
| 0.127 | 0.14 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.117 DBMET02876 0.131 0.117 DBMET02877 | DBMET02877 | |
| 0.075 | 0.088 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.049 DBMET02876 0.095 0.049 DBMET02877 | DBMET02877 | |
| 0.06 | 0.073 | 0.087 | Antineoplastic antibiotic | 0.087 0.053 DBMET02876 0.087 0.053 DBMET02877 | DBMET02877 | |
| 0.018 | 0.032 | 0.024 | Leukotriene D4 antagonist | 0.024 0.02 DBMET02876 0.024 0.02 DBMET02877 | DBMET02877 | |
| 0.028 | 0.043 | 0.04 | Tubulin agonist | 0.04 0.015 DBMET02876 0.04 0.015 DBMET02877 | DBMET02877 | |
| 0.025 | 0.04 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET02876 0.037 0.021 DBMET02877 | DBMET02877 | |
| 0.021 | 0.038 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET02876 0.033 0.009 DBMET02877 | DBMET02877 | |
| 0.028 | 0.048 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.049 0.012 DBMET02876 0.049 0.012 DBMET02877 | DBMET02877 | |
| 0.083 | 0.104 | 0.099 | Glutamate (mGluR7) agonist | 0.099 0.062 DBMET02876 0.099 0.062 DBMET02877 | DBMET02877 | |
| 0.078 | 0.099 | 0.083 | Glutamate release inhibitor | 0.083 0.082 DBMET02876 0.083 0.082 DBMET02877 | DBMET02877 | |
| 0.017 | 0.038 | 0.029 | Uridine phosphorylase inhibitor | 0.029 0.019 DBMET02876 0.029 0.019 DBMET02877 | DBMET02877 | |
| 0.022 | 0.044 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 DBMET02876 0.041 0.012 DBMET02877 | DBMET02877 | |
| 0.121 | 0.144 | 0.188 | Platelet adhesion inhibitor | 0.188 0.078 DBMET02876 0.188 0.078 DBMET02877 | DBMET02877 | |
| 0.107 | 0.131 | 0.146 | Protein-tyrosine phosphatase inhibitor | 0.146 0.082 DBMET02876 0.146 0.082 DBMET02877 | DBMET02877 | |
| 0.018 | 0.042 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 DBMET02876 0.032 0.011 DBMET02877 | DBMET02877 | |
| 0.014 | 0.041 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET02876 0.017 0.016 DBMET02877 | DBMET02877 | |
| 0.038 | 0.068 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 DBMET02876 0.045 0.042 DBMET02877 | DBMET02877 | |
| 0.007 | 0.043 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET02876 0.019 0.01 DBMET02877 | DBMET02877 | |
| 0.034 | 0.072 | 0.058 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 DBMET02876 0.058 0.034 DBMET02877 | DBMET02877 | |
| 0.065 | 0.106 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 DBMET02876 0.077 0.056 DBMET02877 | DBMET02877 | |
| 0.105 | 0.15 | 0.176 | Growth hormone agonist | 0.176 0.07 DBMET02876 0.176 0.07 DBMET02877 | DBMET02877 | |
| 0.02 | 0.067 | 0.03 | Hedgehog signaling activator | 0.03 0.012 DBMET02876 0.03 0.012 DBMET02877 | DBMET02877 | |
| 0.064 | 0.115 | 0.15 | Chemokine receptor antagonist | 0.15 0.032 DBMET02876 0.15 0.032 DBMET02877 | DBMET02877 | |
| 0.029 | 0.082 | 0.043 | Microtubule stabilization | 0.043 0.037 DBMET02876 0.043 0.037 DBMET02877 | DBMET02877 | |
| 0.039 | 0.093 | 0.101 | NMDA 2 receptor antagonist | 0.101 0.031 DBMET02876 0.101 0.031 DBMET02877 | DBMET02877 | |
| 0.041 | 0.101 | 0.135 | Prostaglandin F2 alpha antagonist | 0.135 0.005 DBMET02876 0.135 0.005 DBMET02877 | DBMET02877 | |
| 0.092 | 0.159 | 0.143 | Neurotrophic factor | 0.143 0.065 DBMET02876 0.143 0.065 DBMET02877 | DBMET02877 | |
| 0.021 | 0.096 | 0.041 | Antimetabolite | 0.041 0.039 DBMET02876 0.041 0.039 DBMET02877 | DBMET02877 | |
| 0.031 | 0.106 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET02876 0.063 0.023 DBMET02877 | DBMET02877 | |
| 0.041 | 0.13 | 0.109 | CC chemokine receptor antagonist | 0.109 0.03 DBMET02876 0.109 0.03 DBMET02877 | DBMET02877 | |
| 0.119 | 0.21 | 0.191 | Vasodilator | 0.191 0.112 DBMET02876 0.191 0.112 DBMET02877 | DBMET02877 | |
| 0.019 | 0.125 | 0.047 | Mannosidase inhibitor | 0.047 0.028 DBMET02876 0.047 0.028 DBMET02877 | DBMET02877 | |
| 0.06 | 0.17 | 0.142 | Glutamate receptor antagonist | 0.142 0.056 DBMET02876 0.142 0.056 DBMET02877 | DBMET02877 | |
| 0.126 | 0.279 | 0.216 | Peptidyltransferase inhibitor | 0.216 0.081 DBMET02876 0.216 0.081 DBMET02877 | DBMET02877 | |
| 0.119 | 0.338 | 0.307 | Toll-Like receptor 7 agonist | 0.307 0.106 DBMET02876 0.307 0.106 DBMET02877 | DBMET02877 | |
| 0.127 | 0.347 | 0.239 | Caspase 3 stimulant | 0.239 0.122 DBMET02876 0.239 0.122 DBMET02877 | DBMET02877 | |
| 0.115 | 0.346 | 0.303 | Toll-Like receptor agonist | 0.303 0.109 DBMET02876 0.303 0.109 DBMET02877 | DBMET02877 | |
| 0.009 | 0.244 | 0.022 | Phosphodiesterase 9A inhibitor | 0.022 0.021 DBMET02876 0.022 0.021 DBMET02877 | DBMET02877 | |
| 0.01 | 0.4 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.016 DBMET02876 0.036 0.016 DBMET02877 | DBMET02877 | |
| 0.006 | 0.446 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.029 DBMET02876 0.03 0.029 DBMET02877 | DBMET02877 | |
| 0.007 | 0.6 | 0.055 | Protein kinase C eta inhibitor | 0.055 0.038 DBMET02876 0.055 0.038 DBMET02877 | DBMET02877 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |